Hallett David 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Hallett David（CIK 2006495）在 1 家公司共报告 6 笔 SEC Form 4 内部人交易（最近一笔 2026-08-18）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-18 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Scientific Officer | 卖出 | 26,657 | $84,236 |
| 2026-05-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Scientific Officer | 卖出 | 26,657 | $81,037 |
| 2026-02-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Scientific Officer | 卖出 | 11,908 | $41,559 |
| 2026-02-10 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Scientific Officer | 买入 | 502,064 | $0 |
| 2026-02-10 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Scientific Officer | 买入 | 24,254 | $0 |
| 2026-02-10 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Scientific Officer | 卖出 | 11,400 | $45,372 |
来源：SEC Form 4 申报文件 · 截至 2026-08-18